tm
Seeing Is Believing
tm
Seeing Is Believing
LYEL is currently covered by 2 analysts with an average price target of $2.01. This is a potential upside of $1.09 (118.48%) from yesterday's end of day stock price of $0.92.
Lyell Immunopharma's activity chart (see below) currently has 9 price targets and 15 ratings on display. The stock rating distribution of LYEL is 44.44% HOLD and 55.56% BUY.
Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 21.33 days.
Highest price target for LYEL is $1, Lowest price target is $1, average price target is $2.01.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 12-Nov-2024. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of LYEL, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1
$-0.1 (-9.09%)
$1
16 days ago
(12-Nov-2024)
3/10 (30%)
$-0.17 (-14.53%)
64
Hold
$4
$2.9 (263.64%)
$7
1 years 10 months 4 days ago
(24-Jan-2023)
0/3 (0%)
$0.96 (31.58%)
Buy
$7
$5.9 (536.36%)
$30
2 years 17 days ago
(11-Nov-2022)
0/2 (0%)
$2.47 (54.53%)
What is LYEL (Lyell Immunopharma) average time for price targets to be met?
Which analyst has the current highest performing score on LYEL (Lyell Immunopharma) with a proven track record?
Which analyst has the current lower performing score on LYEL (Lyell Immunopharma) with a proven track record?
Which analyst has the most public recommendations on LYEL (Lyell Immunopharma)?
Which analyst is the currently most bullish on LYEL (Lyell Immunopharma)?
Which analyst is the currently most reserved on LYEL (Lyell Immunopharma)?
